1. Home
  2. LIND vs IOVA Comparison

LIND vs IOVA Comparison

Compare LIND & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lindblad Expeditions Holdings Inc.

LIND

Lindblad Expeditions Holdings Inc.

HOLD

Current Price

$25.80

Market Cap

2.0B

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$8.58

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIND
IOVA
Founded
1979
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
2011
2008

Fundamental Metrics

Financial Performance
Metric
LIND
IOVA
Price
$25.80
$8.58
Analyst Decision
Strong Buy
Buy
Analyst Count
4
10
Target Price
$22.25
$9.00
AVG Volume (30 Days)
773.1K
13.9M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
5.97
14.84
EPS
0.07
N/A
Revenue
N/A
N/A
Revenue This Year
$10.98
$47.74
Revenue Next Year
$6.98
$40.31
P/E Ratio
$362.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.37
$1.76
52 Week High
$35.00
$9.36

Technical Indicators

Market Signals
Indicator
LIND
IOVA
Relative Strength Index (RSI) 30.65 58.06
Support Level $24.79 $7.66
Resistance Level $30.00 $9.36
Average True Range (ATR) 1.26 0.45
MACD -0.64 -0.10
Stochastic Oscillator 10.99 27.37

Price Performance

Historical Comparison
LIND
IOVA

About LIND Lindblad Expeditions Holdings Inc.

Lindblad Expeditions Holdings Inc provides expedition cruising and adventure travel services. The company operates in two segments: Lindblad and Land Experiences, of which Lindblad generates the vast majority of its revenue. It offers itineraries that feature up-close encounters with wildlife, nature, history, and culture, as well as promote guest empowerment and interactivity. It operates expeditions on intimately-scaled ships and interaction between guests, crew, and the teams of scientists, naturalists, researchers, and photographers that participate in the expeditions. Lindblad operates a fleet of twelve owned expedition ships and five seasonal charter vessels under the Lindblad brand.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: